# Amphastar Nanjing Pharmaceuticals Inc – FDA Inspection, Apr 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/4fc6bd5e-2e76-4169-ba5f-13b6dada7297
Source feed: FDA_Inspections

> FDA inspection 1017547 of Amphastar Nanjing Pharmaceuticals Inc, April 28, 2017. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017547
- Company Name: Amphastar Nanjing Pharmaceuticals Inc
- Inspection Date: 2017-04-28
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1291882 - 2025-09-19](https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/8c11e7e8-9c3d-43fb-940f-6748a59595b1)
- FDA Inspection 1269036 - 2025-03-07
- FDA Inspection 1107981 - 2019-10-11
- FDA Inspection 1036696 - 2017-10-26
- FDA Inspection 969870 - 2016-04-29

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-t-middendorf/0fea23f5-ffe6-49a0-ac33-780317707c71)
- [Issuing Officer](https://www.keypedia.com/people/krishna-ghosh/70e1d05f-dfc6-4e74-84c0-db739f037e1d)

Company: https://www.keypedia.com/companies/amphastar-nanjing-pharmaceuticals-inc/ad29710e-4137-4608-933e-8292394dcbc7

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8